RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsDowngradesPrice Target
RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.
RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.